![Uttam Yashwant Patil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uttam Yashwant Patil
Chief Executive Officer at
ABVC BIOPHARMA, INC.
Net worth: 102 123 $ as of 2026-05-30
Profile
Uttam Yashwant Patil currently works at AiBtl BioPharma, Inc., as Co-Chief Executive Officer from 2025, ABVC BioPharma, Inc., as Chief Executive & Financial Officer from 2023, Biokey, Inc., as Chief Operating & Scientific Officer from 2023, and Rgene Corp., as Manager-Research & Development from 2023.
Dr. Patil received his doctorate degree from National Tsing-Hua University and undergraduate degree and graduate degree from the University of Pune.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ABVC BIOPHARMA, INC. 0.28% | 2026-02-26 | 72,428 ( 0.28% ) | 102 123 $ | 2026-05-30 |
Uttam Yashwant Patil active positions
| Companies | Position | Start |
|---|---|---|
| ABVC BIOPHARMA, INC. | Chief Executive Officer | 2023-06-22 |
Biokey, Inc.
 Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Chief Operating Officer | 2023-04-30 |
Rgene Corp.
 Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Chief Tech/Sci/R&D Officer | 2023-04-30 |
Training of Uttam Yashwant Patil
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
National Tsing-Hua University
 National Tsing-Hua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pune
 University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABVC BioPharma, Inc.
 ABVC BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops drugs and medical devices in the fields of oncology, ophthalmology and central nervous system | Health Technology |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Health Technology |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
- Stock Market
- Insiders
- Uttam Yashwant Patil
